David N. Cook
53Patents
20h-index
39Co-inventors
88Inventor score
Filing activity: Nov 14, 1994 → Jan 26, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9028841B2 | Synergistic bacterial compositions and methods of production and use thereof | Emerging Cross-Sectional Technologies | 235 | Active |
| US9011834B1 | Compositions and methods | Emerging Cross-Sectional Technologies | 234 | Active |
| US8906668B2 | Synergistic bacterial compositions and methods of production and use thereof | Emerging Cross-Sectional Technologies | 132 | Active |
| US9180147B2 | Compositions and methods | Emerging Cross-Sectional Technologies | 88 | Active |
| US9446080B2 | Compositions and methods | Emerging Cross-Sectional Technologies | 79 | Active |
| US9533014B2 | Synergistic bacterial compositions and methods of production and use thereof | Emerging Cross-Sectional Technologies | 75 | Active |
| US5691132A | Method for inactivating pathogens in red cell compositions using quinacrine mustard | Chemistry; Metallurgy | 58 | Expired |
| US5559250A | Treating red blood cell solutions with anti-viral agents | Chemistry; Metallurgy | 52 | Expired |
| US9585921B2 | Compositions and methods | Emerging Cross-Sectional Technologies | 44 | Active |
| US6171777A | Treating blood or blood product with a compound having a mustard and a nucleic acid binding moiety | Chemistry; Metallurgy | 42 | Expired |
| US6270952A | Methods for quenching pathogen inactivators in biological materials | Human Necessities | 39 | Expired |
| US6093725A | Frangible compounds for pathogen inactivation | Chemistry; Metallurgy | 36 | Expired |
| US6177441A | Treating red blood cell solutions with anti-viral agents | Human Necessities | 34 | Expired |
| US6410219B1 | Treating blood or blood products with compounds which have a mustard, azirdinium or aziridine group and a nucleic acid binding group | Chemistry; Metallurgy | 31 | Expired |
| US6143490A | Treating blood or blood product with a compound having a mustard and a nucleic acid binding moiety | Chemistry; Metallurgy | 30 | Expired |
| US6514987B1 | Frangible compounds for pathogen inactivation | Chemistry; Metallurgy | 28 | Expired |
| US7935804B2 | Engineered Listeria and methods of use thereof | Chemistry; Metallurgy | 26 | Active |
| US6709810B2 | Methods for quenching pathogen inactivators in biological materials | Human Necessities | 26 | Expired |
| US9855303B2 | Compositions and methods | Emerging Cross-Sectional Technologies | 25 | Active |
| US7293985B2 | Methods for quenching pathogen inactivators in biological materials | Human Necessities | 20 | Expired |
| US10076546B2 | Network-based microbial compositions and methods | Human Necessities | 20 | Active |
| US10064900B2 | Methods of populating a gastrointestinal tract | Emerging Cross-Sectional Technologies | 19 | Active |
| US7842289B2 | Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof | Emerging Cross-Sectional Technologies | 19 | Active |
| US10864235B2 | Synergistic bacterial compositions and methods of production and use thereof | Emerging Cross-Sectional Technologies | 19 | Active |
| US10064901B2 | Compositions and methods | Emerging Cross-Sectional Technologies | 18 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.